 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | multi-CAR-T cell therapy / SZGIMI
New P1/2 trial, CAR T-Cell Therapy: Multi-CAR-T Cells Targeting B Cell Lymphomas (clinicaltrials.gov) - Jun 11, 2020
P1/2, N=11, Recruiting, Sponsor: Shenzhen Geno-Immune Medical Institute